Searched over 200M research papers
8 papers analyzed
These studies suggest that high cholesterol is associated with increased risks of cardiovascular diseases, liver disorders, diabetes, and other health issues, while extremely high HDL-C levels can increase the risk of mortality and stroke.
20 papers analyzed
High cholesterol levels, particularly extremely high levels of high-density lipoprotein cholesterol (HDL-C), have been linked to an increased risk of atherosclerotic cardiovascular disease (CVD) mortality. Studies have shown that individuals with extremely high HDL-C levels face a significantly higher risk of coronary heart disease and ischemic stroke . This association is particularly evident among current drinkers, suggesting lifestyle factors may exacerbate the risks associated with high cholesterol.
Extremely high HDL-C levels are also associated with an increased risk of all-cause mortality. A meta-analysis of cohort studies found that individuals with very high HDL-C levels had a 15% higher risk of all-cause mortality compared to those with normal HDL-C levels. This highlights the complex role of cholesterol in overall health and the potential dangers of excessively high levels.
Excess cholesterol accumulation in various tissues can lead to several health issues beyond cardiovascular diseases. High cholesterol levels are implicated in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as well as in diabetes. These conditions are often associated with oxidative and endoplasmic reticulum (ER) stress, which further complicates their management .
Chronic kidney disease and Alzheimer's disease are also linked to high cholesterol levels. The accumulation of cholesterol in tissues can exacerbate these conditions, contributing to their progression and severity. This underscores the importance of managing cholesterol levels to prevent or mitigate these serious health issues.
While statins are effective in lowering cholesterol levels and reducing cardiovascular risks, they can have adverse effects on skeletal muscles. Common side effects include muscle cramping, soreness, fatigue, and weakness. In rare cases, statins can cause rapid muscle breakdown, leading to severe complications. These side effects are often more pronounced during or after strenuous exercise, highlighting the need for careful monitoring of patients on statin therapy.
Cholesterol-lowering medications, such as bile acid sequestrants, can cause mild gastrointestinal side effects. These include symptoms like bloating, constipation, and abdominal discomfort. However, these medications are generally well-tolerated and can significantly lower low-density lipoprotein (LDL) cholesterol levels when combined with statins.
High cholesterol levels are associated with elevated high-sensitivity C-reactive protein (hs-CRP) levels, an inflammatory biomarker linked to an increased risk of atherosclerotic coronary heart disease. Adding bile acid sequestrants to statin therapy has been shown to reduce hs-CRP levels, suggesting a potential benefit in managing inflammation associated with high cholesterol.
High cholesterol levels pose significant risks to cardiovascular health and are implicated in various other diseases, including liver disease, diabetes, chronic kidney disease, and Alzheimer's disease. While cholesterol-lowering medications are effective, they can have side effects, particularly on skeletal muscles and gastrointestinal function. Managing cholesterol levels is crucial for preventing these adverse effects and improving overall health outcomes.
Most relevant research papers on this topic